Connect with us

Technology

Medical Gas Blenders Market to Grow by USD 582 Million (2024-2028), Driven by Aging Population and Chronic Disease Prevalence, with AI Impacting Market Trends – Technavio

Published

on

NEW YORK, Nov. 18, 2024 /PRNewswire/ — Report on how AI is redefining market landscape – The global medical gas blenders market size is estimated to grow by USD 582 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  5.42%  during the forecast period. Growing geriatric population and rising prevalence of chronic diseases is driving market growth, with a trend towards increasing use of respiratory gas blenders in nicus. However, stringent regulations on design and manufacturing of medical gas blenders  poses a challenge.Key market players include BioMed Devices, DEHAS Medical Systems GmbH, EKU Elektronik GmbH, ESAB Corp., Genstar Technologies Co. Inc., Guangdong Pigeon Medical Apparatus Co. Ltd., Halma Plc, HVS Oliver Hornla GmbH and Co. KG, Inspiration Healthcare Group Plc., MCQ Instruments, medin Medical Innovations GmbH, Ningbo David Medical Device Co. Ltd., Precision Medical Inc., S S Technomed P Ltd., Scanatron Technics AG, SHANGHAI AMCAREMED TECHNOLOGY Co. Ltd., TG Eakin Ltd., Weyer GmbH, WITT Gasetechnik GmbH and Co KG, and Zhengzhou Dison Instrument And Meter Co. Ltd..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Medical Gas Blenders Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.42%

Market growth 2024-2028

USD 582 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

5.04

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Germany, China, Canada, and India

Key companies profiled

BioMed Devices, DEHAS Medical Systems GmbH, EKU Elektronik GmbH, ESAB Corp., Genstar Technologies Co. Inc., Guangdong Pigeon Medical Apparatus Co. Ltd., Halma Plc, HVS Oliver Hornla GmbH and Co. KG, Inspiration Healthcare Group Plc., MCQ Instruments, medin Medical Innovations GmbH, Ningbo David Medical Device Co. Ltd., Precision Medical Inc., S S Technomed P Ltd., Scanatron Technics AG, SHANGHAI AMCAREMED TECHNOLOGY Co. Ltd., TG Eakin Ltd., Weyer GmbH, WITT Gasetechnik GmbH and Co KG, and Zhengzhou Dison Instrument And Meter Co. Ltd.

Market Driver

The Medical Gas Blenders Market is experiencing significant growth due to the increasing number of surgical procedures, driven by diseases such as cancer in the elderly population. Anesthesia delivery machines require a precise flow of gases like oxygen and nitrous oxide for controlled anesthesia during surgery. Manual handling of gases is being replaced by automated handling and electronic control systems. The gas blending system, breathing system, ventilating system, and gas exhaust system are essential components of anesthetic devices. Oxygen, nitrous oxide, and other anesthesia gases are in high demand in hospitals and Ambulatory Surgical Centers. The VMR industry report provides forward-looking analysis and actionable data on gas flows, automated processing, and information management systems. Electronic gas mixing and gas monitoring ensure patient safety and respiratory monitoring. Self-inspection and data systems facilitate efficient gas source management. Outpatient surgeries, hernia operations, hip replacements, and knee replacements are common procedures that utilize medical gas blenders. Chronic conditions, heart surgeries, brain surgeries, lung surgeries, orthopaedic surgeries, gastrointestinal surgeries, inhalable anesthetics, intravenous anesthesia, and cosmetic procedures all require anesthetic devices. Emerging economies and the geriatric population’s adoption of these technologies are key growth drivers. Electric power is a critical factor in the functioning of these devices. The market pitches, business plans, presentations, and proposals highlight the importance of these trends in the medical industry. Sample VMR reports are available with discounts. 

The medical gas blenders market is witnessing significant growth due to the increasing demand for respiratory gas blenders in healthcare facilities. Neonates and infants, particularly those born prematurely, require additional oxygen to breathe properly after birth. The use of medical gas blenders ensures the delivery of precise oxygen mixtures to these patients, preventing potential brain damage or even death. Vendors, such as Ohio Medical, provide reliable and advanced gas blenders, including the NEO2 blend and low-flow models, designed for Neonatal Intensive Care Units (NICUs), ensuring accurate gas mixing for optimal patient care. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

Market Challenges

The Medical Gas Blenders Market faces several challenges in the healthcare industry. Diseases such as lung cancer, breast cancer, and prostate cancer require various surgical procedures, leading to an increased demand for anesthesia delivery machines and controlled anesthesia gases like oxygen and nitrous oxide. Manual handling of gases and knob adjustments in anesthetic devices can lead to errors. Electronic control and automated handling are solutions, but cost and self-inspection requirements add complexity. The VMR industry report highlights the importance of gas source, gas blending system, breathing system, ventilating system, gas exhaust system, data system, and electronic gas mixing for efficient gas monitoring and respiratory monitoring. Adoption of automated processing for air/oxygen and melting gas is increasing in Ambulatory Surgical Centers, Hospitals, and OECD countries. Emerging economies, geriatric population, and outpatient surgeries present growth opportunities. Electric power reliability and cost are key considerations. The market pitches, business plans, presentations, and proposals must address these challenges and provide actionable data and forward-looking analysis. Types of cancer, surgical admissions, and chronic conditions like heart and brain surgeries, hernia operations, hip replacement, and knee replacement drive demand for anesthesia gases and anesthetic devices. Inhalable anesthetics and intravenous anesthesia are alternatives. Medical practitioners and cosmetic procedures also utilize medical gas blenders. Medical tourism is a growing trend.Medical gas blenders are essential devices used in healthcare settings to deliver oxygen and heliox therapy, as well as life support in Intensive Care Units (ICUs) and emergency situations. The design and manufacturing of these devices are subject to stringent regulations to ensure safety and effectiveness. In Europe, medical gas blenders must comply with the Medical Device Directive (MDD), Directive 2007/47/EC, and Council Directive 93/42/EEC. Additionally, the oxygen used in medical gas blenders must meet regulatory standards, such as those set by the American National Standards Institute (ANSI) Z86 in the US. The production, handling, manufacturing, control, and distribution of medicinal oxygen are subject to rigorous regulations to maintain quality and safety.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This medical gas blenders market report extensively covers market segmentation by  

End-user 1.1 Hospitals1.2 Ambulatory surgical centers1.3 Pharmaceuticals1.4 Homecare settings1.5 Academic and research institutionsProduct 2.1 Dual flow2.2 Tube flowGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Hospitals-  The hospital segment led the global medical gas blenders market in 2023, driven by the increasing patient population and subsequent demand for medical gas blenders. These devices are essential for delivering precise oxygen concentrations and flows to patients with hypoxic conditions. Medical gas blenders play a vital role in hospital care by enabling healthcare professionals to administer oxygen safely and accurately. With patient safety being a top priority, medical gas blenders are indispensable tools for ensuring optimal oxygen level monitoring. Consequently, the growing need for medical gas blenders in hospitals will fuel market expansion throughout the forecast period.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

The Medical Gas Blenders Market refers to the production and supply of devices used for blending and delivering anesthesia gases for surgical procedures. These gases, including oxygen and nitrous oxide, are essential for controlled anesthesia during surgery. Manual handling of gases using knobs on anesthesia delivery machines has evolved to electronic control and automated handling for improved precision and safety. Gas blending systems ensure accurate mixing of anesthesia gases from various gas sources. The breathing system delivers gases to the patient, while the ventilating system assists in breathing. Gas exhaust systems remove waste gases, and data systems monitor gas flow, oxygen levels, and patient vitals. Electronic gas mixing and gas monitoring ensure safe and efficient delivery of anesthesia gases. Regular self-inspection is crucial to maintain the functionality and safety of medical gas blenders.

Market Research Overview

The Medical Gas Blenders Market is a critical segment of the healthcare industry, supplying essential gases for various medical applications, including surgical procedures and anesthesia delivery. Diseases such as lung cancer, breast cancer, prostate cancer, and chronic conditions necessitate surgeries, leading to an increased demand for medical gases. Elderly populations in emerging economies and the growing number of outpatient surgeries in Ambulatory Surgical Centers and Hospitals are significant factors driving market growth. Medical Gas Blenders are used to blend and deliver anesthesia gases, including oxygen, nitrous oxide, and other anesthetic gases, in controlled quantities. These systems consist of a gas source, gas blending system, breathing system, ventilating system, gas exhaust system, data system, and electronic gas mixing with gas monitoring and respiratory monitoring. Manual and electronic control options are available, with automated handling and self-inspection features. The VMR Industry Report provides forward-looking analysis, actionable data, and pitches, business plans, presentations, and proposals for investors and industry professionals. The report covers gas flows, automated processing, air/oxygen, melting gas, and various types of surgeries, including hernia operations, hip replacements, knee replacements, heart surgeries, brain surgeries, lung surgeries, orthopaedic surgeries, gastrointestinal surgeries, inhalable anesthetics, intravenous anesthesia, and cosmetic procedures. The adoption of electronic control and automated handling in medical gas blenders is increasing due to their advantages over manual handling, including improved accuracy, safety, and efficiency. The market is expected to grow significantly due to the increasing number of surgical admissions, electric power usage, and the geriatric population’s rising healthcare needs. OECD statistics indicate that surgical procedures accounted for over 50% of all healthcare spending in 2019. In conclusion, the Medical Gas Blenders Market is a vital sector of the healthcare industry, providing essential gases for various medical applications, and its growth is driven by demographic and technological factors.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

End-userHospitalsAmbulatory Surgical CentersPharmaceuticalsHomecare SettingsAcademic And Research InstitutionsProductDual FlowTube FlowGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/medical-gas-blenders-market-to-grow-by-usd-582-million-2024-2028-driven-by-aging-population-and-chronic-disease-prevalence-with-ai-impacting-market-trends—technavio-302308022.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Asian American Engineer of the Year Award and Conference Announces First Phase of 2025-2026 Awardees

Published

on

By

SANTA CLARA, Calif., May 1, 2026 /PRNewswire/ — The Asian American Engineer of the Year Award (AAEOY) Executive Committee announces the AAEOY 2025-2026 first phase awardees as follows:

Distinguished Lifetime Achievement Award

Mr. Lip-Bu Tan, CEO, Intel Corporation

Distinguished Leadership in Science and Technology Award

Dr. Arun Majumdar, Dean of the Stanford Doerr School of Sustainability, Stanford University

Executive of the Year Award

Dr. Xiaodong Che, Chief Technology Officer, Western DigitalDr. Sam Heidari, CEO, LumotiveDr. Jungwon Lee, Corporate Executive Vice President, Samsung ElectronicsDr. Liu Ren, Vice President & Chief Scientist, Bosch ResearchMr. Brandon Wang, Vice President, Synopsys

Engineer of the Year Award

Ms. Vivian Ye, Principal Member of Technical Staff, AT&T

Most Promising Engineer of the Year Award

Mr. Max Fang, Director of Architecture, AmbarellaMr. Johnny Ho, CSO & Co-founder, Perplexity AI

The AAEOY Award has been presented annually since 2002 as a cornerstone of the National Engineers Week program, honoring distinguished Asian American professionals across academia, public service, and industry. Since its inception, the AAEOY has recognized over 300 honorees — including nine Nobel Laureates, pioneering scholars, prominent corporate executives, and an astronaut — serving as a beacon of inspiration for the global STEM community. After a series of impactful ceremonies nationwide, the 2025-2026 AAEOY Award and Conference returns to the heart of innovation in Silicon Valley at the Santa Clara Convention Center on September 18-19, 2026.

For more information regarding the AAEOY program, awardees, and event registration, please visit www.aaeoy.org.

The Chinese Institute of Engineers in USA (CIE-USA), founded in 1917, is a nonprofit professional organization that promotes science, technology, engineering, and mathematics (STEM); supports professional advancement and leadership development; and recognizes the achievements of Asian American professionals through flagship programs such as the Asian American Engineer of the Year (AAEOY) Awards. One of the oldest and most prestigious Chinese American engineering associations in the United States, CIE-USA has seven regional chapters nationwide and hosts events throughout the year.

View original content to download multimedia:https://www.prnewswire.com/news-releases/asian-american-engineer-of-the-year-award-and-conference-announces-first-phase-of-2025-2026-awardees-302760569.html

SOURCE AAEOY

Continue Reading

Technology

Larry Kellerman, Fermi’s Chief Power Officer and Architect of Its 17 GW Energy Infrastructure, Accepts Board Nomination

Published

on

By

DALLAS, May 1, 2026 /PRNewswire/ — Toby Neugebauer, co-founder and largest shareholder of Fermi America (NASDAQ & LSE: FRMI), today announced that he has nominated Larry Kellerman to join the Fermi Board of Directors. Kellerman, who serves as Chief Power Officer at Fermi America, is the architect of the Company’s 17-gigawatt powered data center campus in Amarillo, Texas — the largest private energy grid in America.

Kellerman is co-founder and Managing Partner of Twenty First Century Utilities and brings more than four decades of power industry and finance expertise to the role. His career spans senior leadership positions at Goldman Sachs, El Paso Corporation, and I Squared Capital. Kellerman said he was honored by the nomination and would be pleased to serve if approved by the Board.

“I appreciate everything that Toby has manifested in Fermi and know that no other human could have created the enterprise and its many thoughtfully interconnected elements as quickly, as effectively, and in as value-accretive a manner as Toby’s leadership has been able to deliver.”
— Larry Kellerman, Chief Power Officer and Board Nominee, Fermi America

For Neugebauer, the choice was crystal clear. Kellerman, who has worked alongside Neugebauer since the earliest days of Project Matador knows Fermi’s power story better than anyone.

“When I came up with the idea of Project Matador, I knew that Larry Kellerman was the one person I needed to convert a really great idea into a really great reality. His knowledge of power and the future of powering data centers is unmatched. Larry is uniquely qualified to steward Fermi as a Board member, and I couldn’t be more pleased with his willingness to serve.”
— Toby Neugebauer, Co-Founder, Fermi America

View original content:https://www.prnewswire.com/news-releases/larry-kellerman-fermis-chief-power-officer-and-architect-of-its-17-gw-energy-infrastructure-accepts-board-nomination-302760575.html

SOURCE Toby Neugebauer

Continue Reading

Technology

EAST SIDE GAMES GROUP ANNOUNCES NON-BROKERED PRIVATE PLACEMENT OF UNITS TO RAISE UP TO $3.5 MILLION

Published

on

By

VANCOUVER, BC, May 1, 2026 /CNW/ – East Side Games Group (TSX: EAGR) (OTC: EAGRF) (the “Company”), Canada’s leading free-to-play mobile game group, announces a non-brokered private placement of 31,818,182  units (a “Unit”) at $0.11 per Unit (the “Unit Price”), for total gross proceeds of up to $3.5 million. 

Each Unit will be comprised of one common share and one full whole warrant (a “Warrant”).  Each whole Warrant will be exercisable at $0.14 per share (the “Exercise Price”) for a period of three years from issuance. The Warrants will be subject to standard anti-dilution adjustments.

The private placement will be offered in reliance on prospectus exemptions, and any securities sold will be subject to a four month statutory hold period.  The private placement is not anticipated to have any material impact on the control of the Company, nor is it anticipated that any new control persons would be created as a result of the private placement.

It is anticipated that Derek Lew, a director of the Company, will participate in the private placement for an amount of $1.0 million for 9,090,909 Units. As at the date of this news release, Mr. Lew holds 1,667,244 common shares of the Company (2.17%). If the private placement is completed as anticipated, Mr. Lew will hold 10,758,153 common shares (representing 9.89% of the common shares anticipated to be outstanding upon completion of the private placement on a partially diluted basis), 9,090,909 Warrants and 250,000 incentive stock options. Upon exercise of his Warrants, Mr. Lew would own 19,849,062 common shares representing 16.84% of the then issued and outstanding common shares assuming no other share issuances.

The TSX Company Manual requires shareholder approval be obtained  for private placements if the maximum number of common shares issuable under the private placement represents an amount that is more than 25% of the total outstanding common shares as at the date of the press release (pursuant to Section 607(g)). Disinterested shareholder approval must be obtained (excluding those shareholders participating in this private placement and their associates and affiliates) if the number of common shares issued and issuable to insiders under a private placement exceeds 10% of the Company’s issued and outstanding common shares as of the date hereof (pursuant to Section 607(g)(ii)).

As: (a) the private placement is for up to 31,818,182 Units (being equivalent to 41.35% of the Company’s outstanding shares as at the date of this press release), (b) Mr. Lew’s subscription for 9,090,909 Units represents an amount that is equivalent to 11.81% of the Company’s outstanding shares as at the date of this press release, and (c) the Warrants comprising the Units have an exercise price of $0.14 per share (and the five day VWAP is $0.144 per share), the Company has obtained written consent from Jason Bailey, the Company’s CEO and a director, in support of the private placement in accordance with Section 604(d) of the TSX Company Manual.  Mr. Bailey holds more than 50% of the Company’s outstanding shares as at the date of this press release.

The net proceeds from the private placement will be used to repay indebtedness owing to the Royal Bank of Canada (RBC) and for operating expenses and general working capital. Mr. Bailey commented, “With this funding in place, we are on solid footing to continue our disciplined approach to completing the business’s turnaround. With our core portfolio of well performing titles, we have a solid foundation to rebuild upon. We feel we have a strong runway, pipeline and team to execute toward a positive 2026,” [and] “I’d like to thank our existing shareholders for their support and guidance through a difficult 2025 and look forward to achieving the results that will allow this Company, our capital markets strategy and employees to reach its potential.”

The Company’s board of directors considers the private placement to be in the best interests of its shareholders, after having taken into account other alternative forms of financing.  In the course of its review, the Company considered other replacement debt financing, the Company’s ongoing cashflow from operations, as well as ongoing operating expenses, one-off necessary expenditures and the Company’s debt load, within the larger context of the analysis detailed in its press release dated March 31, 2026 as to the re-orienting of the Company’s overall business strategy. 

The Company anticipates that the private placement will close on or before May 8, 2026, subject to acceptance by the TSX.

The Company reserves the right to pay finder’s fees in the form of common shares (in lieu of cash fees) and broker warrants to arm’s length finders in connection with the private placement to arm’s length parties, in accordance with TSX policies. No finder’s fee will be paid to any non-arm’s length parties, nor with respect to subscriptions from non-arm’s length parties.  A maximum number of 1,363,636 common shares (to be issued at $0.11 per share for a total value of $150,000) and a maximum number of 1,254,545 broker warrants will be issuable, assuming the private placement is fully subscribed.  Each broker warrant will entitle the holder to acquire one common share at $0.14 per common share (the “Broker Warrant Exercise Price”) for a period of three years form issuance.  

The maximum number of securities issuable under the private placement is 66,254,545 common shares, comprising 31,818,182 common shares comprising the Units, 31,818,182 common shares issuable upon exercise of the Warrants, 1,363,636 common shares to be issued as finder’s fees, and 1,254,545 common shares issuable upon exercise of the broker warrants, which represents an amount equivalent to 86.10% of the total outstanding common shares as at the date of this press release on a non-diluted basis, without taking into effect the private placement itself, or approximately 46.27% of the Company’s total issued and outstanding common shares following completion of the private placement (being 143,200,825 shares anticipated to be outstanding on a partially diluted basis, assuming the private placement is fully subscribed, full issuance of the finder’s fee shares and full exercise of the Warrants and broker warrants). The Unit Price represents a 22% discount to the Company’s five-day volume-weighted trading price of its common shares on the TSX as at the time of submitting the Company’s application to TSX (the “Market Price”). Market Price and the Exercise Price and the Broker Warrant Exercise Price represent a 2.47% discount to the Market Price.

The total number of common shares expected to be issued to insider (Mr. Lew) under the private placement is 18,181,818 (consisting of 9,090,909 common shares and 9,090,909 common shares issuable upon full exercise of Warrants), representing 23.63% of the total outstanding common shares as at the date of this press release on a non-diluted basis, without taking into effect the private placement itself, or 12.70% of the Company’s total issued and outstanding common shares following completion of the private placement (being 143,200,825 shares anticipated to be outstanding on a partially diluted basis, assuming the private placement is fully subscribed, full issuance of the finder’s fee shares and full exercise of the Warrants and the broker warrants).

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States.  The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and may not be offered or sold within the United states or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws, or an exemption from such registration is available.

ABOUT EAST SIDE GAMES GROUP

ESGG is a leader in free-to-play mobile gaming, thrilling players with unforgettable experiences that spark lifelong fandom. Fueled by an entrepreneurial spirit, we are driven by creativity, flawless execution, and a laser-focused strategy. We develop and publish both original and licensed IP titles, license our cutting-edge GameKit(s) platforms, and strategically acquire studios or games to expand our family.

Headquartered in Vancouver with around 100 talent-dense team members, we operate over a dozen titles under East Side Games (“ESG”) and LDRLY (Technologies) Inc. (“LDRLY”). Together, we’re crafting, launching, and publishing mobile games across our own studios and an extended Game Kit partner network-reaching players on iOS and Android worldwide.

We power our success through in-app purchases (“IAP”) — offering exclusive, game-enhancing virtual items — and in-game advertising. To keep growing, we focus on captivating audiences, keeping them engaged, and unlocking exciting new ways to monetize. We’ll drive this momentum by launching bold new titles, enriching our current lineup, innovating discovery, expanding into fresh markets, and exploring new distribution platforms.

Additional information about the Company continues to be available under its legal name, East Side Games Group Inc., at www.sedarplus.ca.

Forward-looking Information

Certain statements in this news release constitute forward-looking information or forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are often, but not always, identified by the use of words such as “expects,” “anticipates,” “plans,” “intends,” “believes,” “estimates,” “projects,” “may,” “will,” “would,” “could,” “should,” and similar expressions. Forward-looking statements in this news release include, without limitation, statements regarding the proposed private placement.

Forward-looking statements are based on management’s current expectations, estimates, projections and assumptions. Such forward-looking statements are subject to significant risks, uncertainties and other factors that could cause actual results or events to differ materially from those expressed or implied by such statements, including, without limitation, risks relating to the Company’s ability to complete the proposed private placement as described, and relating to general economic, market and industry conditions. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

SOURCE East Side Games Group Inc.

Continue Reading

Trending